These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28220881)

  • 1. Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies.
    Zhang TN; Gao SY; Shen ZQ; Li D; Liu CX; Lv HC; Zhang Y; Gong TT; Xu X; Ji C; Wu QJ
    Sci Rep; 2017 Feb; 7():43085. PubMed ID: 28220881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
    Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
    BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertraline use during pregnancy and the risk of major malformations.
    Bérard A; Zhao JP; Sheehy O
    Am J Obstet Gynecol; 2015 Jun; 212(6):795.e1-795.e12. PubMed ID: 25637841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies.
    Wang S; Yang L; Wang L; Gao L; Xu B; Xiong Y
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25991012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies.
    Shen ZQ; Gao SY; Li SX; Zhang TN; Liu CX; Lv HC; Zhang Y; Gong TT; Xu X; Ji C; Wu QJ; Li D
    Br J Clin Pharmacol; 2017 Apr; 83(4):909-922. PubMed ID: 27770542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
    Källén BA; Otterblad Olausson P
    Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):301-8. PubMed ID: 17216624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to selective noradrenalin reuptake inhibitors during the first trimester of pregnancy and risk of congenital malformations: A meta-analysis of cohort studies.
    Lou ZQ; Zhou YY; Zhang X; Jiang HY
    Psychiatry Res; 2022 Oct; 316():114756. PubMed ID: 35932572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies.
    Gao SY; Wu QJ; Zhang TN; Shen ZQ; Liu CX; Xu X; Ji C; Zhao YH
    Br J Clin Pharmacol; 2017 Oct; 83(10):2134-2147. PubMed ID: 28513059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
    Uguz F
    Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713
    [No Abstract]   [Full Text] [Related]  

  • 12. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
    Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
    N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
    Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C
    Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fetal safety of fluoxetine: a systematic review and meta-analysis.
    Riggin L; Frankel Z; Moretti M; Pupco A; Koren G
    J Obstet Gynaecol Can; 2013 Apr; 35(4):362-369. PubMed ID: 23660045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine in the first trimester and the prevalence of congenital malformations.
    Cole JA; Ephross SA; Cosmatos IS; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1075-85. PubMed ID: 17729379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.
    Reefhuis J; Devine O; Friedman JM; Louik C; Honein MA;
    BMJ; 2015 Jul; 351():h3190. PubMed ID: 26156519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.
    Wemakor A; Casson K; Garne E; Bakker M; Addor MC; Arriola L; Gatt M; Khoshnood B; Klungsoyr K; Nelen V; O'Mahoney M; Pierini A; Rissmann A; Tucker D; Boyle B; de Jong-van den Berg L; Dolk H
    Eur J Epidemiol; 2015 Nov; 30(11):1187-98. PubMed ID: 26148560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
    Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
    Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Bérard A; Ramos E; Rey E; Blais L; St-André M; Oraichi D
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.